Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

AtriCure (ATRC) Net Margin (2016 - 2025)

AtriCure (ATRC) has disclosed Net Margin for 16 consecutive years, with 1.25% as the latest value for Q4 2025.

  • On a quarterly basis, Net Margin rose 1378.0% to 1.25% in Q4 2025 year-over-year; TTM through Dec 2025 was 2.14%, a 746.0% increase, with the full-year FY2025 number at 2.14%, up 746.0% from a year prior.
  • Net Margin was 1.25% for Q4 2025 at AtriCure, up from 0.2% in the prior quarter.
  • In the past five years, Net Margin ranged from a high of 137.82% in Q3 2021 to a low of 28.54% in Q1 2021.
  • A 5-year average of 3.37% and a median of 8.06% in 2023 define the central range for Net Margin.
  • Peak YoY movement for Net Margin: skyrocketed 14686bps in 2021, then crashed -15256bps in 2022.
  • AtriCure's Net Margin stood at 18.77% in 2021, then skyrocketed by 75bps to 4.74% in 2022, then tumbled by -94bps to 9.19% in 2023, then plummeted by -36bps to 12.53% in 2024, then surged by 110bps to 1.25% in 2025.
  • Per Business Quant, the three most recent readings for ATRC's Net Margin are 1.25% (Q4 2025), 0.2% (Q3 2025), and 4.55% (Q2 2025).